The seemingly imminent repeal of the Affordable Care Act’s insurance requirement, which could happen next week as part of the final passage of Republicans’ broad tax overhaul, has focused attention on Congress’ potential next moves on health care, including a bipartisan plan to shore up the insurance markets.

But that plan, sponsored by Sens. Lamar Alexander (R., Tenn.) and Patty Murray (D., Wash.), is losing support as more health analysts say it could raise costs for many consumers. The bill would restore payments to insurers, allowing them to cut premiums, but in doing so it would reduce the tax credits that are pegged in part to the premium costs of certain plans.

. . .

Pro-Obamacare lawmakers and activists are urging the Trump administration to allow a grace period for open enrollment so that people who have trouble using healthcare.gov are able to finish their applications.

The Trump administration has not said if it will allow a grace period, but an announcement about a final decision may not come until Friday.

During the 2015 and 2016 open enrollments, the Obama administration announced extensions on the same day as the deadline. The decision was made in 2015 to extend the deadline by two days because of “unprecedented demand,” and in 2016, the deadline was extended by four days as about 1 million people left their names at the call center to keep their place in line.

. . .

Last November, the American people sent a message to Washington: Get things done. With Republican control of both chambers of Congress and the Oval Office, the time to enact pro-growth, pro-innovation policies that benefit American workers and businesses is now.

This month, Congress and the Trump administration have the opportunity to significantly boost one of America’s most vibrant and growing industries by suspending the federal excise tax on medical devices. This misguided tax is set to go back into effect on Jan. 1, which is why Reps. Jackie Walorski, R-Ind., and Erik Paulsen, R-Minn., recently introduced legislation that would suspend the medical device tax for five years.

. . .